Skip to main content

Advertisement

Log in

Analysis of PROS1 mutations and clinical characteristics in three Chinese families with hereditary protein S deficiency

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

We report three heterozygous PROS1 mutations that caused type I protein S deficiency in three unrelated Chinese families. We measured protein S activity and antigen levels for all participants, screened them for mutations in the PROS1 gene. And we employed the calibrated automated thrombin generation (CAT) method to investigate thrombin generation. Numerous bioinformatics tools were utilized to analyze the conservation, pathogenicity of mutation, and spatial structure of the protein S. Phenotyping analysis indicated that all three probands exhibited simultaneous reduced levels of PS:A, TPS:Ag, and FPS:Ag. Genetic testing revealed that proband A harbored a heterozygous c.458_458delA (p.Lys153Serfs*6) mutation in exon 5, proband B carried a heterozygous c.1687C>T (p.Gln563stop) mutation in exon 14, and proband C exhibited a heterozygous c.200A>C (p.Glu67Ala) mutation in exon 2. Bioinformatic analysis predicted that the p.Lys153Serfs*6 frameshift mutation and the p.Gln563stop nonsense mutation in the protein S were classified as “disease-causing.” The identification of the novel mutation p.Lys153Serfs*6 in PROS1 enriches the Human Genome Database. Our research suggests that these three mutations (p.Lys153Serfs*6, p.Gln563stop, and p.Glu67Ala) are possibly responsible for the decreased level of protein S in the three families. Furthermore, the evidence also supports the notion that individuals who are asymptomatic but have a family history of PSD can benefit from genetic analysis of the PROS1 gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

The data that support the conclusions of this study are available from the corresponding author upon request. Further inquiries can be directed to the corresponding author.

Abbreviations

PROS1 gene:

protein S1 gene

PSD:

protein S deficiency

CAT:

calibrated automated thrombin generation

PS:A:

protein S activity

TPS:Ag:

total protein S antigen

FPS:Ag:

free protein S antigen

PC:

protein C

APC:

activated PC

TFPI:

tissue factor inhibitor

VTE:

venous thromboembolism

MRI:

magnetic resonance imaging

CT:

computed tomography

PE:

pulmonary embolism

MRV:

magnetic resonance venography

PT:

prothrombin time

APTT:

activated partial thromboplastin time

D-D:

D-dimer

PC:A:

protein C activity

AT:A:

anti-thrombin activity

PPP:

platelet-poor plasma

ELISA:

enzyme-linked immunosorbent assay

TGT:

thrombin generation test

ETP:

endogenous thrombin potential

sTM:

soluble recombinant human thrombomodulin

PCR:

polymerase chain reaction

PDB:

Protein Data Bank

EGF:

epidermal growth factor

LGR:

liver growth factor

TSR:

thrombin-sensitive region

PF:

purpura fulminans

References

  1. Juhl D, Kuta P, Shneyder M et al (2021) Two novel variants in the protein S gene PROS1 are associated with protein S deficiency and thrombophilia. Acta Haematol 144(2):222–226. https://doi.org/10.1159/000508525

    Article  CAS  PubMed  Google Scholar 

  2. Ameku K, Higa M (2018) Rivaroxaban treatment for warfarin-refractory thrombosis in a patient with hereditary protein S deficiency. Case Rep Hematol 23(2018):5217301. https://doi.org/10.1155/2018/5217301

    Article  Google Scholar 

  3. Miyata T, Maruyama K, Banno F et al (2016) Thrombophilia in East Asian countries: are there any genetic differences in these countries? Thromb J 14(Suppl 1):25. https://doi.org/10.1186/s12959-016-0109-x

    Article  PubMed  PubMed Central  Google Scholar 

  4. Majumder R, Nguyen T (2021) Protein S: function, regulation, and clinical perspectives. Curr Opin Hematol 28(5):339–344. https://doi.org/10.1097/MOH.0000000000000663

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Majid Z, Tahir F, Ahmed J et al (2020) Protein C deficiency as a risk factor for stroke in young adults: a review. Cureus 12(3):e7472. https://doi.org/10.7759/cureus.7472

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wypasek E, Undas A (2013) Protein C and protein S deficiency - practical diagnostic issues. Adv Clin Exp Med 22(4):459–467

    PubMed  Google Scholar 

  7. Gierula M, Ahnström J (2020) Anticoagulant protein S-new insights on interactions and functions. J Thromb Haemost 18(11):2801–2811. https://doi.org/10.1111/jth.15025

    Article  CAS  PubMed  Google Scholar 

  8. Takeyama M, Nogami K, Saenko EL et al (2008) Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa. Br J Haematol 143(3):409–420. https://doi.org/10.1111/j.1365-2141.2008.07366.x

    Article  CAS  PubMed  Google Scholar 

  9. Khan F, Tritschler T, Kahn SR et al (2021) Venous thromboembolism. Lancet 398(10294):64–77. https://doi.org/10.1016/S0140-6736(20)32658-1

    Article  CAS  PubMed  Google Scholar 

  10. Labrouche-Colomer S, Soukarieh O, Proust C et al (2020) A novel rare c.-39C>T mutation in the PROS1 5′UTR causing PS deficiency by creating a new upstream translation initiation codon. Clin Sci (Lond) 134(10):1181–1190. https://doi.org/10.1042/CS20200403

    Article  CAS  PubMed  Google Scholar 

  11. Li L, Wu X, Wu W et al (2023) A case-report of the unprovoked thrombotic event in a patient with thymoma and severe FVII deficiency. Thromb J 21(1):52. https://doi.org/10.1186/s12959-023-00494-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Zhou J, Shen W, Gu Y et al (2020) Compound heterozygous mutations identified in severe type I protein S deficiency impaired the secretion of protein S. J Clin Pathol 73(1):7–13. https://doi.org/10.1136/jclinpath-2019-205956

    Article  CAS  PubMed  Google Scholar 

  13. Ikejiri M, Wada H, Yamada N et al (2017) High prevalence of congenital thrombophilia in patients with pregnancy-related or idiopathic venous thromboembolism/pulmonary embolism. Int J Hematol 105(3):272–279. https://doi.org/10.1007/s12185-016-2111-2

    Article  PubMed  Google Scholar 

  14. Maurissen LF, Castoldi E, Simioni P et al (2010) Thrombin generation-based assays to measure the activity of the TFPI-protein S pathway in plasma from normal and protein S-deficient individuals. J Thromb Haemost 8(4):750–758. https://doi.org/10.1111/j.1538-7836.2010.03743.x

    Article  CAS  PubMed  Google Scholar 

  15. Schweingruber C, Rufener SC, Zünd D et al (2013) Nonsense-mediated mRNA decay - mechanisms of substrate mRNA recognition and degradation in mammalian cells. Biochim Biophys Acta 1829(6-7):612–623. https://doi.org/10.1016/j.bbagrm.2013.02.005

    Article  CAS  PubMed  Google Scholar 

  16. Hackeng TM, Yegneswaran S, Johnson AE et al (2000) Conformational changes in activated protein C caused by binding of the first epidermal growth factor-like module of protein S. Biochem J 349(Pt 3):757–764. https://doi.org/10.1042/bj3490757

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Yamazaki T, Hamaguchi M, Katsumi A et al (1995) A quantitative protein S deficiency associated with a novel nonsense mutation and markedly reduced levels of mutated mRNA. Thromb Haemost 74(2):590–595

    Article  CAS  PubMed  Google Scholar 

  18. Biguzzi E, Razzari C, Lane DA et al (2005) Molecular diversity and thrombotic risk in protein S deficiency: the PROSIT study. Hum Mutat 25(3):259–269. https://doi.org/10.1002/humu.20136

    Article  CAS  PubMed  Google Scholar 

  19. Seligsohn U, Lubetsky A (2001) Genetic susceptibility to venous thrombosis. N Engl J Med 344(16):1222–1231. https://doi.org/10.1056/NEJM200104193441607

    Article  CAS  PubMed  Google Scholar 

  20. ten Kate MK, van der Meer J (2008) Protein S deficiency: a clinical perspective. Haemophilia 14(6):1222–1228

    Article  PubMed  Google Scholar 

  21. Siegal DM, Eikelboom JW et al (2021) Variations in incidence of venous thromboembolism in low-, middle-, and high-income countries. Cardiovasc Res 117(2):576–584. https://doi.org/10.1093/cvr/cvaa044

    Article  CAS  PubMed  Google Scholar 

  22. Mizukami K, Nakabayashi T, Naitoh S et al (2006) One novel and one recurrent mutation in the PROS1 gene cause type I protein S deficiency in patients with pulmonary embolism associated with deep vein thrombosis. Am J Hematol 81:787–797. https://doi.org/10.1002/ajh.20689

    Article  CAS  PubMed  Google Scholar 

  23. Phillippe HM, Hornsby LB, Treadway S et al (2014) Inherited thrombophilia. J Pharm Pract 27(3):227–233. https://doi.org/10.1177/0897190014530390

    Article  PubMed  Google Scholar 

  24. Stevens SM, Woller SC, Bauer KA et al (2016) Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis 41(1):154–164. https://doi.org/10.1007/s11239-015-1316-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Colvin BT, Machin SJ, Barrowcliffe TW et al (1993) Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for Haematology. J Clin Pathol 46(12):1069–1070. https://doi.org/10.1136/jcp.46.12.1069

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was funded by the Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province (2022E10022) and the Science and Technology Plan Fund of Wenzhou (Y20220125).

Author information

Authors and Affiliations

Authors

Contributions

All the authors have made significant contributions to the study’s conception and design, data acquisition, analysis and interpretation, as well as to the drafting and critical revision of the manuscript for important intellectual content. Furthermore, all the authors have provided their final approval for the submitted version of the article.

Corresponding author

Correspondence to Xiaoli Chen.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, F., Zhou, X., Jin, Y. et al. Analysis of PROS1 mutations and clinical characteristics in three Chinese families with hereditary protein S deficiency. Ann Hematol 103, 653–662 (2024). https://doi.org/10.1007/s00277-023-05607-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05607-6

Keywords

Navigation